A SYED & CO LIMITED

Company number 03385869 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: A SYED & CO LIMITED

1. Financial Health Score: C+

Explanation: The company shows signs of recovery from historical distress but is experiencing a concerning decline in its latest financial position. While the balance sheet remains positive and current liabilities have reduced, the significant contraction in assets and net worth between 2024 and 2025 raises questions about the practice's trajectory. The small scale of operations and minimal capital base make this business vulnerable to even modest adverse events.


2. Key Vital Signs

Vital Sign 2025 2024 Trend Assessment
Net Assets £21,384 £33,616 ↓ 36.4% ⚠️ Concerning decline
Total Assets £28,622 £48,505 ↓ 41.0% ⚠️ Significant contraction
Current Assets £25,563 £47,661 ↓ 46.4% 🔴 Major reduction
Current Liabilities £7,238 £14,889 ↓ 51.4% ✅ Healthy reduction
Net Current Assets £18,325 £32,772 ↓ 44.1% ⚠️ Working capital halved
Fixed Assets £3,059 £844 ↑ 262.7% ✅ Investment increase
Current Ratio 3.53:1 3.20:1 ↑ Improved ✅ Strong liquidity
Share Capital £6 £6 → Unchanged ⚠️ Minimal capital base

Historical Context – Net Assets Progression:

Year Net Assets Year-on-Year Change
2016 £4,864 -
2017 (£1,103) ↓ Distress
2018 (£2,736) ↓ Worst position
2019 £3,265 ↑ Recovery begins
2020 £10,310 ↑ Steady growth
2021 £18,439 ↑ Continued growth
2022 £19,675 ↑ Modest growth
2023 £30,376 ↑ Strong growth
2024 £33,616 ↑ Peak position
2025 £21,384 ↓ Significant decline

3. Diagnosis

Overall Condition: Stable but Weakening

Think of this company as a patient who recovered from a serious illness (the 2017-2018 negative net assets period) and enjoyed several years of improving health, but is now showing symptoms of a relapse.

Symptoms Analysis:

🩺 Positive Indicators (Signs of Wellness):

  1. Liquidity is Strong – The current ratio of 3.53:1 means the company has £3.53 in current assets for every £1 of short-term debts. This is like having excellent oxygen saturation levels – the business can comfortably meet its immediate obligations.

  2. Liabilities Reduced Significantly – Current liabilities dropped by over 51%, from £14,889 to £7,238. This suggests the company has been paying down debts, similar to a patient successfully reducing harmful cholesterol levels.

  3. Historical Recovery – The journey from negative net assets of (£2,736) in 2018 to positive net assets of £33,616 by 2024 demonstrates resilience and effective rehabilitation.

  4. Fixed Asset Investment – The increase in fixed assets from £844 to £3,059 suggests capital investment, possibly in equipment or technology – a positive sign of forward planning.

⚠️ Concerning Symptoms:

  1. Rapid Asset Contraction – Total assets fell by 41% in a single year. This is akin to sudden weight loss – while sometimes intentional, it warrants investigation. In a micro-entity accounting practice, this likely represents either: - Significant drawings/dividends by the director - Reduced fee income leading to lower cash balances - A combination of both factors

  2. Net Worth Erosion – The 36.4% decline in net assets represents a substantial reduction in the company's financial cushion. If this were a patient's immune system, we'd say their reserves have been depleted.

  3. Minimal Capital Base – With only £6 in share capital, the business operates with virtually no permanent equity investment. This is like having no financial bone marrow – the company lacks the structural foundation to generate resilience during difficult periods.

  4. Scale Limitations – As a micro-entity with 2 employees (including the director), this practice has limited capacity to absorb shocks or invest in growth initiatives.

What the Numbers Don't Tell Us:

As a micro-entity, A SYED & CO LIMITED files abbreviated accounts that exclude the profit and loss statement. This is like a medical assessment where key test results are missing. We cannot determine: - Revenue levels or trends - Profit margins - Operating costs - Director remuneration or dividend distributions - The proportion of asset decline attributable to drawings versus trading losses


4. Recommendations

Immediate Actions (Urgent Care):

  1. Investigate the Decline – The director should diagnose the root cause of the 41% asset contraction. Was this driven by legitimate dividend extraction (healthy) or by trading losses (concerning)? Understanding the "why" behind the numbers is essential.

  2. Monitor Cash Flow Vigilantly – With current assets having nearly halved, maintaining positive cash flow is critical. Implement 13-week rolling cash flow forecasts to detect any early warning signs of liquidity strain.

  3. Review Debtor Levels – The drop in current assets may partly reflect reduced trade debtors. Ensure fee billing and collection processes remain robust to prevent cash from being tied up in unpaid invoices.

Medium-Term Actions (Preventative Care):

  1. Strengthen the Capital Base – Consider retaining more profits within the business rather than distributing them as dividends. A stronger equity position provides resilience against future downturns – building up the company's financial "immune system."

  2. Diversify Revenue Streams – As a small accounting practice, dependency on a limited client base creates concentration risk. Explore advisory services, cloud accounting packages, or niche specializations to broaden the revenue base.

  3. Build a Cash Reserve – Target a minimum cash reserve equivalent to 3-6 months of operating costs. This acts as a financial "safety net" for unexpected slow periods or client losses.

Long-Term Strategic Considerations:

  1. Succession Planning – With a single director and minimal share capital, the business is entirely dependent on one individual. Consider what happens if the director is unable to work – this represents a significant business continuity risk.

  2. Growth Investment – The increase in fixed assets is encouraging. Continue investing in technology, training, and systems that improve efficiency and allow the practice to serve more clients without proportionally increasing costs.


Prognosis

Cautiously Optimistic with Monitoring Required

The company has demonstrated remarkable recovery from its 2017-2018 distress period, building net assets from negative territory to over £33,000. However, the significant decline in the latest year raises a yellow flag. If the asset reduction reflects planned dividend extraction by a profitable practice, the underlying business remains healthy. If it signals deteriorating trading conditions, the prognosis becomes more concerning.

The strong liquidity position (current ratio of 3.53:1) provides comfort that short-term obligations can be met. However, the minimal capital base and single-director dependency mean this business remains structurally fragile. Regular financial check-ups – particularly monitoring the trend in net assets over the next 12-24 months – will be essential to confirm whether this is a temporary dip or the beginning of a more serious decline.


Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 3 September 2026